亚麻醉剂量艾司氯胺酮联合TPVB对胸腔镜肺癌根治术患者应激反应和术后疼痛的影响
收稿日期: 2024-12-23
修回日期: 2025-04-11
录用日期: 2025-08-02
网络出版日期: 2025-08-06
基金资助
上海市卫健委临床研究面上项目(202240159)
Effects of Sub-Anesthesia Dose of Esketamine Combined with TPVB on Stress Response and Pain After Thoracoscopic Radical Resection of Lung Cancer
Received date: 2024-12-23
Revised date: 2025-04-11
Accepted date: 2025-08-02
Online published: 2025-08-06
目的:探究亚麻醉剂量艾司氯胺酮联合胸椎旁神经阻滞(TPVB)对胸腔镜肺癌根治术患者应激反应和术后疼痛的影响。方法:根据随机数字表法,将90例胸腔镜肺癌根治术患者分为试验组(亚麻醉剂量艾司氯胺酮联合TPVB联合全麻)和对照组(TPVB联合全麻),每组各45例。对比两组患者围术期情况、应激指标、术后疼痛、镇痛效果及不良反应发生情况。结果:与术前比较,两组患者术后3 d时血清血清皮质醇(Cor)、去甲肾上腺素(NE)和β-内啡肽(β-EP)水平均升高(P<0.05),试验组术后3 d时血清Cor、NE及β-EP水平低于对照组(P<0.05);试验组术后6、12、24、48 h静息和活动疼痛视觉模拟评分(VAS)低于对照组(P<0.05);试验组神经病理性疼痛发生率为6.67%(3例/45例),低于对照组的22.22%(10例/45例)(P<0.05)。试验组首次按压自控镇痛泵(PCIA)的时间晚于对照组,PCIA按压次数和24 h内PCIA中舒芬太尼用量少于对照组(P<0.05)。两组麻醉相关不良反应发生率比较,差异无统计学意义(P>0.05)。结论:亚麻醉剂量艾司氯胺酮联合TPVB可有效减轻胸腔镜肺癌根治术患者应激反应和术后疼痛,降低神经病理性疼痛的发生率,且不额外增加不良反应。
殷颖
,
彭生
.
亚麻醉剂量艾司氯胺酮联合TPVB对胸腔镜肺癌根治术患者应激反应和术后疼痛的影响
Objective: To explore the effects of sub-anesthesia dose of esketamine combined with thoracic paravertebral block (TPVB) on stress response and pain after thoracoscopic radical resection of lung cancer.Methods: According to random number table method, 90 patients undergoing thoracoscopic radical resection of lung cancer were divided into control group (TPVB general anesthesia) and experimental group (sub-anesthesia dose of esketamine combined with TPVB general anesthesia), 45 cases in each group. The perioperative situations, stress indexes, postoperative pain, analgesic effect and occurrence of adverse reactions in the two groups were compared.Results: At the 3 d after surgery, levels of serum cortisol (Cor), norepinephrine (NE) and β-endorphin (β-EP) increased in both groups (P<0.05), and were lower in experimental group than those in the control group (P<0.05). At the 6, 12, 24 and 48 h after surgery, scores of visual analogue scale (VAS) for path under rest and motor states were lower in the experimental group than thne in the control group (P<0.05). The incidence of neuropathic pain was lower in the experimental group than that in the control group [6.67% (3 cases/45 cases) vs. 22.22% (10 cases/45 cases), P<0.05]. The first compression time of patient controlled intravenous analgesia (PCIA) was later in the experimental group than that in the control group, compression frequency of PCIA and sufentanil dosage within 24h after PCIA were lower in the experimental group (P<0.05). The difference in the incidence of anesthesia-related adverse reactions between the two groups was not statistically significant (P>0.05).Conclusion: Sub-anesthesia dose of esketamine combined with TPVB can effectively relieve stress response and pain, and reduce the incidence of neuropathic pain after thoracoscopic radical resection of lung cancer, and does not increase adverse reactions additionally.
[1] 郭兰伟,蔡林,朱称心,等.中国人群肺癌疾病负担分析[J].中华流行病学杂志,2024,45(5):626-632.
[2] Schuler M, Bölükbas S, Darwiche K, et al. Personalized treatment for patients with lung cancer[J].Dtsch Arztebl Int,2023,120(17):300-310.
[3] 刘晨,韩瑞丽,郑兰兰,等.经皮穴位电刺激对胸腔镜肺癌根治术患者术中循环抑制的影响[J].临床麻醉学杂志,2023,39(12):1287-1292.
[4] Feray S, Lemoine A, Aveline C, et al. Pain management after thoracic surgery or chest trauma[J].Minerva Anestesiol,2023,89(11):1022-1033.
[5] Song N, Yang Y, Zheng Z, et al. Effect of esketamine added to propofol sedation on desaturation and hypotension in bidirectional endoscopy: a randomized clinical trial[J].JAMA Netw Open,2023,6(12):e2347886.
[6] 周珑艳,刘咏春,卢锡华,等.艾司氯胺酮对胸腔镜肺叶切除术后疼痛及炎症应激的影响[J].重庆医学,2023,52(19):2924-2929.
[7] Yan H, Chen W, Chen Y, et al. Opioid-free versus opioid-based anesthesia on postoperative pain after thoracoscopic surgery: the use of intravenous and epidural esketamine[J].Anesth Analg,2023,137(2):399-408.
[8] 中华医学会,中华医学会肿瘤学分会,中华医学会杂志社.中华医学会肺癌临床诊疗指南(2018版)[J].中华肿瘤杂志,2018,40(12):935-964.
[9] Heller GZ, Manuguerra M, Chow R. How to analyze the visual analogue scale: myths, truths and clinical relevance[J].Scand J Pain,2016,13:67-75
[10] Bennett M.The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs[J].Pain,2001,92(1-2):147-157.
[11] Lumsden S, Lai E, Cata JP. The ideal regional block after video-assisted thoracoscopic surgery: do we have it?[J].J Thorac Dis,2024,16(4):2674-2676.
[12] 刘晓,杨程杰,李亚红,等.竖脊肌平面阻滞与胸椎旁神经阻滞用于成人胸腔镜肺叶切除术后镇痛效果的Meta分析[J].中国内镜杂志,2023,29(1):8-17.
[13] 陈韦东,谭炜浩,钟锦涛,等.胸椎旁神经阻滞技术的研究进展[J].中国临床解剖学杂志, 2021, 39(1):111-114.
[14] Chenesseau J, Fourdrain A, Pastene B, et al. Effectiveness of surgeon-performed paravertebral block analgesia for minimally invasive thoracic surgery: a randomized clinical trial[J].JAMA Surg,2023,158(12):1255-1263.
[15] 王凯,李宝强,葛磊,等.超声引导下罗哌卡因联合艾司氯胺酮椎旁阻滞技术在胸腔镜肺叶切除术中的应用价值[J].生物医学工程与临床,2023,27(3):310-315.
[16] Liu LL, Hu JH, Pan JJ, et al. An intraoperative sub-anesthetic dose of esketamine on postoperative depressive symptoms in perimenopausal women with breast cancer undergoing modified radical mastectomy: protocol for a randomized, triple-blinded, controlled trial[J].Int J Gen Med,2023,16:3373-3381.
[17] 袁静静,陈书涵,谢艳乐,等.亚麻醉剂量艾司氯胺酮对胸腔镜手术后阿片类药物镇痛消耗量的影响[J].中华医学杂志,2022,102(15):1108-1113.
[18] 任苏恩,李砚,刘磊,等.艾司氯胺酮联合超声引导下TPVB对胸腔镜全麻手术患者术后恢复的影响[J].海南医学,2024,35(9):1279-1282.
[19] 王中玉,李娟,王安琪,等.亚麻醉剂量艾司氯胺酮对行膝关节置换术老年患者麻醉诱导期间血流动力学和应激反应的影响[J].中华实用诊断与治疗杂志,2022,36(1):88-92.
[20] Dai B, Huo Y. A subanesthetic dose of esketamine combined with hip peripheral nerve block has good sedative and analgesic effects in elderly patients undergoing total hip arthroplasty: a randomized-controlled trial[J].Jt Dis Relat Surg,2023,34(3):548-556.
[21] 王润珠,纪木火,杨建军,等.胸腔镜术后慢性疼痛患者的危险因素及恢复质量[J].医学研究生学报, 2022,35(2):161-164.
[22] Feeney A, Papakostas GI.Pharmacotherapy: ketamine and esketamine[J]. Psychiatr Clin North Am,2023,46(2):277-290.
/
| 〈 |
|
〉 |